Dermata Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 12.00 K | $60.24 K | 0.00% | 1.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 10.18 K | $225 | -5.10% | 0.99% |
| UBS GROUP AG | 11/13/2025 | 1.28 K | $22 | -31.97% | 0.12% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dermata Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Dermata Therapeutics, Inc.. The most heavily invested institutionals were:
BOOTHBAY FUND MANAGEMENT, LLC: 12,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 10,176
UBS Group AG: 1,279
TWO SIGMA SECURITIES, LLC: 0
Empery Asset Management, LP: 175,000
2.28% of Dermata Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 198.46 K shares in the last 24 months. This purchase volume represents approximately $3.97 K in transactions.